Back to Research Home
GRDNGuardian Pharmacy Services, Inc.
Consumer Staples · Retail-Drug Stores and Proprietary Stores · Mid
$39.44−0.38%
As of 23 Oct 2026Mkt cap $2.5B
Stage 13
AVOID
Fundamentals
33.7/75
Technical
8.0/15
Independent
41.7/90
GCAE viewFundamental /75 is below the Stage 13 acceptable-business floor
Price
- 1M
- −5.6%
- 3M
- −4.9%
- 6M
- +5.0%
- 1Y
- +40.9%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- —
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- —
- FCF yield
- —
Quality
- ROIC
- 26.6%
- Operating margin
- 3.9%
- FCF margin
- 6.0%
- Current ratio
- 1.4x
Growth
- Revenue growth
- +17.9%Latest FY YoY
- Revenue CAGR
- +17.7%
- EPS CAGR
- —
- FCF CAGR
- +11.5%
Capital
- Share-count trend
- —3Y annualised
- Net cash
- $28M-0.3x OCF
Annual trend
- CAGR 2023–2025
- +17.7%
- Latest · 2025
- $1B
- YoY
- +17.9%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
Fundamental /75 is below the Stage 13 acceptable-business floor
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-11-05
More details & evidence
Production decision
- Stage 13
- AVOID
- Technical state
- approaching-support
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded